ClinicalThought

Share

Program Content

Activities

  • Ibrutinib + Rituximab
    Ibrutinib Plus Rituximab and the Expanding Therapeutic Toolbox for Previously Untreated CLL
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 26, 2020

    Expires: June 25, 2021

  • CLL: Expert Perspectives
    Expert Perspectives on Key New Evidence in CLL Therapy
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: July 28, 2021

    Expires: July 27, 2022

Provided by

ProCE Banner

Supporters

AbbVie Inc.

AstraZeneca

Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC

Pharmacyclics an AbbVie Company

Partners

CLL Society

ProCE Banner